Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, May 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,072 followers.

Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ova... https://t.co/qiMA6NmT6Y

Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids https://t.co/o7GiyzM4Ch

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.